Wells Fargo & Company A Ikido Pharma Inc. Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	N/A	1 Added 3.7%	28 $0
Q3 2023 Nov 13, 2023	SELL	N/A	-6 Reduced 18.18%	27 $0
Q2 2023 Aug 15, 2023	SELL	N/A	-5 Reduced 13.16%	33 $0
Q1 2023 May 12, 2023	BUY	$3.46 - $4.07 $3 - $4	1 Added 2.7%	38 $0
Q4 2022 Feb 13, 2023	BUY	$3.07 - $7.21 $6 - $14	2 Added 5.71%	37 $0
Q3 2022 Nov 14, 2022	BUY	$5.6 - $7.03 $11 - $14	2 Added 6.06%	35 $0
Q2 2022 Aug 12, 2022	BUY	$4.59 - $7.99 $151 - $263	33 New	33 $0

459K

Ticker AIKI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,485,100
Market Cap $20.8M
Description
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.